Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences.
Department of Cardiology, Niigata City General Hospital.
Int Heart J. 2022;63(2):306-311. doi: 10.1536/ihj.21-814.
Since permanent inferior vena cava (IVC) filters increase deep vein thrombosis (DVT), filter retrieval should be performed as possible. Despite the guideline recommendation, IVC filters are not always retrieved in clinical practice. To date, many patients with not-retrieval IVC filters have been prescribed anticoagulant therapy, but the long-term prognosis, including venous thromboembolism (VTE) and bleeding events, remains unknown. In this study, 195 patients who underwent IVC filter implantation between 2006 and 2017 at 3 institutions in Niigata City have been investigated about their deaths, VTE recurrence, and bleeding events. After peaking 2009, the number of IVC filter implantation gradually decreased. During observational period, there were 158 patients with not-retrieval IVC filters (the overall retrieval rate of 19.0%). The not-retrieval group included significantly older and more patients with cancer compared to the retrieval group. Anticoagulation therapy was continued in 88% of the not-retrieval group. During a mean follow-up of 5.0 years, 6 symptomatic DVT events associated with inadequate control of anticoagulation and 13 bleeding events were observed. A total of 52 patients died and only the presence of cancer was prognostic risk factor. Although long-term anticoagulation therapy may be associated with bleeding events, there were few recurrent VTE under optimal anticoagulation. It is anticipated that even if the IVC filter cannot be retrieved, appropriate anticoagulation is useful for prevention of DVT recurrence despite the risk of bleeding.
由于永久性下腔静脉(IVC)过滤器会增加深静脉血栓形成(DVT),因此应尽可能进行过滤器取回。尽管有指南建议,但在临床实践中并非总是取回 IVC 过滤器。迄今为止,许多未取回 IVC 过滤器的患者已接受抗凝治疗,但长期预后,包括静脉血栓栓塞(VTE)和出血事件,仍不清楚。在这项研究中,对 2006 年至 2017 年在新泻市的 3 家机构植入 IVC 过滤器的 195 名患者的死亡、VTE 复发和出血事件进行了调查。2009 年达到峰值后,IVC 过滤器植入数量逐渐减少。在观察期间,有 158 名患者未取回 IVC 过滤器(总取回率为 19.0%)。与取回组相比,未取回组患者年龄明显较大,且癌症患者较多。88%的未取回组继续进行抗凝治疗。在平均 5.0 年的随访期间,观察到 6 例与抗凝控制不足相关的有症状 DVT 事件和 13 例出血事件。共有 52 名患者死亡,只有癌症的存在是预后危险因素。尽管长期抗凝治疗可能与出血事件相关,但在最佳抗凝下,VTE 复发很少。即使无法取回 IVC 过滤器,适当的抗凝也有助于预防 DVT 复发,尽管存在出血风险。